Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

S Bringhen; M D'Agostino; L De Paoli; V Montefusco; AM Liberati; P Galieni; S Grammatico; VE Muccio; F Esma; C De Angelis; P Musto; S Ballanti; M Offidani; MT Petrucci; G Gaidano; P Corradini; A Palumbo; Pieter Sonneveld; M Boccadoro

doi:10.1038/leu.2017.327

Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

S Bringhen
, M D'Agostino
, L De Paoli
, V Montefusco
, AM Liberati
, P Galieni
, S Grammatico
, VE Muccio
, F Esma
, C De Angelis
, P Musto
, S Ballanti
, M Offidani
, MT Petrucci
, G Gaidano
, P Corradini
, A Palumbo
, Pieter Sonneveld
, M Boccadoro

Hematology

Research output: Contribution to journal › Article › Academic › peer-review

25 Citations (Scopus)

106 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	979-985
Number of pages	7
Journal	Leukemia
Volume	32
Issue number	4
DOIs	https://doi.org/10.1038/leu.2017.327
Publication status	Published - 2018

Research programs

EMC OR-01

Access to Document

10.1038/leu.2017.327

REPUB_105574.pdfFinal published version, 406 KB

http://hdl.handle.net/1765/105574

Cite this

Bringhen, S., D'Agostino, M., De Paoli, L., Montefusco, V., Liberati, AM., Galieni, P., Grammatico, S., Muccio, VE., Esma, F., De Angelis, C., Musto, P., Ballanti, S., Offidani, M., Petrucci, MT., Gaidano, G., Corradini, P., Palumbo, A., Sonneveld, P., & Boccadoro, M. (2018). Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma. Leukemia, 32(4), 979-985. https://doi.org/10.1038/leu.2017.327

@article{19d66baf581847cb8ccdf400717cc78f,

title = "Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma",

author = "S Bringhen and M D'Agostino and \{De Paoli\}, L and V Montefusco and AM Liberati and P Galieni and S Grammatico and VE Muccio and F Esma and \{De Angelis\}, C and P Musto and S Ballanti and M Offidani and MT Petrucci and G Gaidano and P Corradini and A Palumbo and Pieter Sonneveld and M Boccadoro",

year = "2018",

doi = "10.1038/leu.2017.327",

language = "Undefined/Unknown",

volume = "32",

pages = "979--985",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "4",

}

Bringhen, S, D'Agostino, M, De Paoli, L, Montefusco, V, Liberati, AM, Galieni, P, Grammatico, S, Muccio, VE, Esma, F, De Angelis, C, Musto, P, Ballanti, S, Offidani, M, Petrucci, MT, Gaidano, G, Corradini, P, Palumbo, A, Sonneveld, P & Boccadoro, M 2018, 'Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma', Leukemia, vol. 32, no. 4, pp. 979-985. https://doi.org/10.1038/leu.2017.327

TY - JOUR

T1 - Phase 1/2 study of weekly carfilzomib, cyclophosphamide, dexamethasone in newly diagnosed transplant-ineligible myeloma

AU - Bringhen, S

AU - D'Agostino, M

AU - De Paoli, L

AU - Montefusco, V

AU - Liberati, AM

AU - Galieni, P

AU - Grammatico, S

AU - Muccio, VE

AU - Esma, F

AU - De Angelis, C

AU - Musto, P

AU - Ballanti, S

AU - Offidani, M

AU - Petrucci, MT

AU - Gaidano, G

AU - Corradini, P

AU - Palumbo, A

AU - Sonneveld, Pieter

AU - Boccadoro, M

PY - 2018

Y1 - 2018

U2 - 10.1038/leu.2017.327

DO - 10.1038/leu.2017.327

M3 - Article

C2 - 29263440

SN - 0887-6924

VL - 32

SP - 979

EP - 985

JO - Leukemia

JF - Leukemia

IS - 4

ER -